Multiple-ascending dose ( MAD ) study : Japanese ( n = @ ) and Caucasians ( n = @ ) received single doses of @ mg or @ mg ticagrelor ( day @ ) , twice-daily @ mg or @ mg ticagrelor , or placebo ( days @ @ ) , and single doses of @ mg or @ mg ticagrelor ( day @ ) .